Skip to main content
ConductScienceScienceDex

Christopher M Jewell

NIH Rank #4521
Unclaimed recordClaim profile
  • R01 Holder
  • Early Career
  • Diverse Portfolio

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID 10585824Search this ID in NIH RePORTER
ScienceDex PI coverage
FY2024 through FY2026Career claims are limited to the years shown.

FY2026 award categories

  • Biomedical Engineering

NIH Funding · FY2024

Linked Award Amount
$2.2M
Full award amounts, FY2024
Award Records
3
Records listing this PI
Award-Linked Rank
#4,521
By linked amount among FY2024 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Christopher M Jewell. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2024 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

FY2024 award records by amount

NIH award records listing Christopher M Jewell as a PI. Multi-PI records show the full award amount for context.

  • 1R44NS137943-01R44
    Manufacturing RNA-based CAR T cells to combat autoantibody-associated autoimmune disorders (AAAD)
    Cartesian Therapeutics, Inc.
    $1.5M
    award amount
  • 5R01AI169686-03R01
    Defining the induction and maintenance of myelin-specific tolerance in T cells and B cells using local lymph node depots
    University of Maryland, College Park
    $554.7K
    award amount
  • 1U44AI184200-01U44
    Targeting BCMA+ Cells with RNA-engineered CAR T cells to treat Lupus: A Phase 2 clinical study
    Cartesian Therapeutics, Inc.
    $149K
    award amount

Award organizations

Organizations that administered FY2024 awards listing Christopher M Jewell as a PI.

Cartesian Therapeutics, Inc.
MD
$1.6M
2 grants
University of Maryland, College Park
MD
$554.7K
1 grant

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2024
    First NIH Award
    Cartesian Therapeutics, Inc.
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    $2M Cumulative Funding
  5. 2024
    Entered Top 50% Nationally
    Ranked #4521
  6. 2024
    Entered Top 25% Nationally
    Ranked #4521
  7. 2025
    Multi-Institutional Research
    Awards at 2 institutions
  8. 2025
    R01 Grant Holder

Explore further

Find collaborators for Christopher M Jewell

Search NIH-funded principal investigators by topic, department, or activity.

Open Find Collaborators →

Benchmark grant budgets

Compare median NIH grant budgets across departments, mechanisms, and years.

Open Grant Budget Benchmark →
Christopher M Jewell | NIH Award Records | ConductScience